Bill
Bill > S1558
MA S1558
To eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
summary
Introduced
01/23/2017
01/23/2017
In Committee
01/23/2017
01/23/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
190th General Court
Bill Summary
For legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.
AI Summary
This bill aims to eliminate the tax deduction for pharmaceutical companies' direct-to-consumer advertising of prescription drugs and devices in Massachusetts. Specifically, it would disallow the deduction for all direct and indirect costs related to advertising prescription drugs and devices to patients, including media advertising, coupons, outreach and persistency programs, and other forms of marketing directed at individuals rather than licensed prescribers. For national or regional programs, the disallowed amount would be the proportionate share of expenses directed to Massachusetts residents.
Committee Categories
Budget and Finance
Sponsors (4)
Last Action
Accompanied a study order, see S2497 (on 04/30/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/190/S1558 |
| Bill | https://malegislature.gov/Bills/190/S1558.pdf |
Loading...